Vocational education Universal Technical Institute (NYSE:UTI) announced better-than-expected revenue in Q1 CY2025, with sales up 12.6% year on year to $207.4 million. The company’s full-year revenue guidance of $830 million at the midpoint came in 2% above analysts’ estimates. Its GAAP profit of $0.21 per share was 72.6% above analysts’ consensus estimates.
Online home goods retailer Wayfair (NYSE:W) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $2.73 billion. Its non-GAAP profit of $0.10 per share was significantly above analysts’ consensus estimates.
Luxury fashion conglomerate Tapestry (NYSE:TPR) announced better-than-expected revenue in Q1 CY2025, with sales up 6.9% year on year to $1.58 billion. The company’s full-year revenue guidance of $6.95 billion at the midpoint came in 1.1% above analysts’ estimates. Its GAAP profit of $0.95 per share was 7.5% above analysts’ consensus estimates.
Restaurant technology provider PAR Technology (NYSE:PAR) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 48.2% year on year to $103.9 million. Its non-GAAP loss of $0.01 per share was 76.7% above analysts’ consensus estimates.
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 16.5% year on year to $324 million. The company expects next quarter’s revenue to be around $317.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.48 per share was 7.7% above analysts’ consensus estimates.
Boutique fitness studio franchisor Xponential Fitness (NYSE:XPOF) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 3.5% year on year to $76.88 million. The company expects the full year’s revenue to be around $320 million, close to analysts’ estimates. Its non-GAAP loss of $0.20 per share was significantly below analysts’ consensus estimates.
Pool products retailer Leslie’s (NASDAQ:LESL) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 6.1% year on year to $177.1 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.34 billion at the midpoint. Its non-GAAP loss of $0.25 per share was 4.6% below analysts’ consensus estimates.
Medical device company ICU Medical (NASDAQ:ICUI) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 5.8% year on year to $599.5 million. Its non-GAAP profit of $1.72 per share was 34.4% above analysts’ consensus estimates.
Secondhand luxury marketplace The RealReal (NASDAQ: REAL) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 11.3% year on year to $160 million. The company expects next quarter’s revenue to be around $159 million, close to analysts’ estimates. Its non-GAAP loss of $0.08 per share was in line with analysts’ consensus estimates.
Refrigerant services company Hudson Technologies (NASDAQ:HDSN) announced better-than-expected revenue in Q1 CY2025, but sales fell by 15.2% year on year to $55.34 million. Its non-GAAP profit of $0.06 per share was significantly above analysts’ consensus estimates.
Personal care company The Honest Company (NASDAQ:HNST) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 12.8% year on year to $97.25 million. Its non-GAAP profit of $0.04 per share was $0.02 above analysts’ consensus estimates.
Semiconductor materials supplier Entegris (NASDAQ:ENTG) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $773.2 million. On the other hand, the company expects next quarter’s revenue to be around $755 million, close to analysts’ estimates. Its non-GAAP profit of $0.67 per share was 2.4% below analysts’ consensus estimates.
Life sciences company Azenta (NASDAQ:AZTA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.2% year on year to $143.4 million. Its non-GAAP profit of $0.05 per share was $0.03 below analysts’ consensus estimates.
Building systems company Limbach (NASDAQ:LMB) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.9% year on year to $133.1 million. The company’s full-year revenue guidance of $620 million at the midpoint came in 1.4% above analysts’ estimates. Its non-GAAP profit of $1.12 per share was significantly above analysts’ consensus estimates.
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $372.8 million. The company’s full-year revenue guidance of $1.57 billion at the midpoint came in 1.8% below analysts’ estimates. Its non-GAAP profit of $1.53 per share was 7.5% below analysts’ consensus estimates.
From a technical analysis perspective, today's price action further confirms what the charts have been telling us: the market is likely positioned for a meaningful decline regardless of news flow.
As usual, China's diplomatic efforts had two faces, one for popular domestic consumption, and one for private engagement with the adversary, in this case the US.
